Holen Sie sich die Stockscreener-App
37.66
4.90%
-1.94
Handel nachbörslich:
37.00
-0.66
-1.75%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HROW?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$39.60
Offen:
$40.58
24-Stunden-Volumen:
609.02K
Relative Volume:
0.84
Marktkapitalisierung:
$1.39B
Einnahmen:
$154.15M
Nettoeinkommen (Verlust:
$-33.58M
KGV:
-39.23
EPS:
-0.96
Netto-Cashflow:
$-20.74M
1W Leistung:
-0.61%
1M Leistung:
-10.61%
6M Leistung:
+34.16%
1J Leistung:
-11.26%
1-Tages-Spanne:
$36.95
$41.24
1-Wochen-Bereich:
$36.77
$41.55
52-Wochen-Spanne:
$20.85
$50.72
Harrow Inc Stock (HROW) Company Profile
Firmenname
Harrow Inc
Sektor
Telefon
615.733.4731
Adresse
1A BURTON HILLS BLVD, NASHVILLE, CA
Vergleichen Sie HROW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
37.66 | 1.47B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Eingeleitet | BTIG Research | Buy |
| 2025-06-10 | Eingeleitet | William Blair | Outperform |
| 2025-02-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-04 | Bestätigt | B. Riley Securities | Buy |
| 2024-04-11 | Eingeleitet | Craig Hallum | Buy |
| 2022-09-08 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-09-24 | Eingeleitet | Aegis Capital | Buy |
| 2021-07-02 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Harrow Inc Aktie (HROW) Neueste Nachrichten
Should I hold or sell Harrow Inc. stock in 2025Portfolio Gains Summary & Risk Managed Investment Entry Signals - newser.com
Harrow, Inc. Hits Day High with 7.65% Surge in Strong Intraday Performance - Markets Mojo
Why Harrow Inc. stock remains on watchlists2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
How Harrow Inc. stock performs in rising dollar environment2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
How Harrow Inc. stock reacts to job market dataJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
What insider trading reveals about Harrow Inc. stockBear Alert & Momentum Based Trading Signals - newser.com
Harrow, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:HROW) 2025-11-19 - Seeking Alpha
How Harrow Inc. stock performs in rate cut cyclesEarnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com
Harrow officially acquires Melt Pharmaceuticals - Eyes On Eyecare
Detecting price anomalies in Harrow Inc. with AIJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
Will Harrow's (HROW) Return to Profitability Reshape Its Growth Narrative? - simplywall.st
Analyzing Harrow Inc. with risk reward ratio charts2025 Biggest Moves & Safe Swing Trade Setups - newser.com
Best data tools to analyze Harrow Inc. stockJuly 2025 PostEarnings & Consistent Return Investment Signals - newser.com
Harrow Completes Its Acquisition of Melt Pharmaceuticals - VisionMonday.com
What analysts say about Harrow Inc stockStock Price Targets & Affordable Growth Investments - earlytimes.in
Will Harrow Inc. stock pay special dividendsMarket Trend Report & Weekly Top Stock Performers List - newser.com
Harrow completes acquisition of Melt Pharmaceuticals By Investing.com - Investing.com Nigeria
Harrow (HROW) Finalizes Acquisition of Melt Pharmaceuticals - GuruFocus
Harrow Health Completes Acquisition of Melt Pharmaceuticals - TipRanks
[8-K] HARROW, INC. Reports Material Event | HROW SEC FilingForm 8-K - Stock Titan
Harrow Closes Melt Pharmaceuticals Acquisition - MarketScreener
Harrow Announces Closing of Acquisition of Melt Pharmaceuticals - The Manila Times
Harrow (Nasdaq: HROW) Closes Melt Deal, Sets MELT-300 NDA Filing for 2027 in U.S. - Stock Titan
What risks investors should watch in Harrow Inc. stockTrend Reversal & Accurate Entry/Exit Alerts - newser.com
Should you hold or exit Harrow Inc. now2025 EndofYear Setup & Daily Risk Controlled Trade Plans - newser.com
Why Harrow Inc. stock is in analyst buy zone2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com
Key resistance and support levels for Harrow Inc.July 2025 Momentum & Low Risk Investment Opportunities - newser.com
Harrow Inc. stock volume spike explainedJuly 2025 News Drivers & Reliable Volume Spike Alerts - newser.com
Custom watchlist performance reports with Harrow Inc.July 2025 Recap & Low Risk Growth Stock Ideas - newser.com
Can Harrow Inc. stock sustain market leadership2025 Price Momentum & Risk Managed Trade Strategies - newser.com
Finanzdaten der Harrow Inc-Aktie (HROW)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.17%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):